Literature DB >> 15252929

Beneficial effects of statins on the kidney.

B Afzali, D J A Goldsmith.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15252929      PMCID： PMC1770345          DOI： 10.1136/jcp.2003.014282

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  19 in total

Review 1.  Should the results of the HOPE study affect nephrological practice? For the HOPE investigators.

Authors:  J F Mann
Journal:  Nephrol Dial Transplant       Date:  2000-04       Impact factor: 5.992

Review 2.  Evolving strategies for renoprotection: non-diabetic chronic renal disease.

Authors:  M W Taal; B M Brenner
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-07       Impact factor: 2.894

3.  Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.

Authors:  G Lambert; N Sakai; B L Vaisman; E B Neufeld; B Marteyn; C C Chan; B Paigen; E Lupia; A Thomas; L J Striker; J Blanchette-Mackie; G Csako; J N Brady; R Costello; G E Striker; A T Remaley; H B Brewer; S Santamarina-Fojo
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

Review 4.  Statins and progressive renal disease.

Authors:  Michele Buemi; Massimino Senatore; Francesco Corica; Carmela Aloisi; Adolfo Romeo; Emanuela Cavallaro; Fulvio Floccari; Domenico Tramontana; Nicola Frisina
Journal:  Med Res Rev       Date:  2002-01       Impact factor: 12.944

5.  Effect of lipid reduction on the progression of renal disease: a meta-analysis.

Authors:  L F Fried; T J Orchard; B L Kasiske
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

Review 6.  Renoprotection: one or many therapies?

Authors:  L A Hebert; W A Wilmer; M E Falkenhain; S E Ladson-Wofford; N S Nahman; B H Rovin
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

Review 7.  The microinflammatory state in uremia: causes and potential consequences.

Authors:  George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 8.  Recent advances in statins and the kidney.

Authors:  H Oda; W F Keane
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

9.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321
View more
  1 in total

1.  Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis.

Authors:  Marko Lucijanic; Davor Galusic; Ivan Krecak; Martina Sedinic; Hrvoje Holik; Vlatka Perisa; Martina Moric Peric; Ivan Zekanovic; Tajana Stoos-Veic; Rajko Kusec
Journal:  Ann Hematol       Date:  2020-08-29       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.